{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:30:01Z","timestamp":1770748201167,"version":"3.49.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s11892-022-01483-y","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T06:02:50Z","timestamp":1657000970000},"page":"423-432","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2474-3250","authenticated-orcid":false,"given":"Noah","family":"Gruber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-8091","authenticated-orcid":false,"given":"Orit","family":"Pinhas-Hamiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"1483_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pedi.12772","volume":"19","author":"AT Hattersley","year":"2018","unstructured":"Hattersley AT, Greeley SAW, Polak M, et al. ISPAD clinical practice consensus guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2018;19:47\u201363.","journal-title":"Pediatr Diabetes"},{"key":"1483_CR2","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.2337\/dc22-S002","volume":"45","author":"B D","year":"2022","unstructured":"D B, A VR, B G, et al. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S17\u201338.","journal-title":"Diabetes Care"},{"key":"1483_CR3","doi-asserted-by":"publisher","unstructured":"Shi D, Motamed M, Mej\u00eda-Ben\u00edtez A, Li L, Lin E, Budhram D, Kaur Y, Meyre D Genetic syndromes with diabetes: a systematic review. Obes Rev. (2021) https:\/\/doi.org\/10.1111\/OBR.13303","DOI":"10.1111\/OBR.13303"},{"key":"1483_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1210\/er.2015-1116","volume":"37","author":"Y Yang","year":"2016","unstructured":"Yang Y, Chan L. Monogenic diabetes: what it teaches us on the common forms of type 1 and type 2 diabetes. Endocr Rev. 2016;37:190\u2013222.","journal-title":"Endocr Rev"},{"key":"1483_CR5","doi-asserted-by":"publisher","unstructured":"\u2022 Pallotta MT, Tascini G, Crispoldi R, Orabona C, Mondanelli G, Grohmann U, Esposito S \u00a0Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med. (2019)\u00a0https:\/\/doi.org\/10.1186\/s12967-019-1993-1An excellent review of Wolfram syndrome, including the etiology, pathogenesis, and future therapeutic interventions.","DOI":"10.1186\/s12967-019-1993-1"},{"key":"1483_CR6","doi-asserted-by":"publisher","unstructured":"Zhang H, Colclough K, Gloyn AL, Pollin TI Monogenic diabetes: a gateway to precision medicine in diabetes. J Clin Invest. (2021) https:\/\/doi.org\/10.1172\/JCI142244","DOI":"10.1172\/JCI142244"},{"key":"1483_CR7","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.2337\/db13-0571","volume":"62","author":"LL Bonnycastle","year":"2013","unstructured":"Bonnycastle LL, Chines PS, Hara T, et al. Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation. Diabetes. 2013;62:3943\u201350.","journal-title":"Diabetes"},{"key":"1483_CR8","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.2337\/db16-1296","volume":"66","author":"E De Franco","year":"2017","unstructured":"De Franco E, Flanagan SE, Yagi T, et al. Dominant ER stress-inducing WFS1 mutations underlie a genetic syndrome of neonatal\/infancy-onset diabetes, congenital sensorineural deafness, and congenital cataracts. Diabetes. 2017;66:2044\u201353.","journal-title":"Diabetes"},{"key":"1483_CR9","doi-asserted-by":"publisher","unstructured":"Delvecchio M, Iacoviello M, Pantaleo A, Resta N Clinical spectrum associated with Wolfram syndrome type 1 and type 2: a review on genotype-phenotype correlations. Int J Environ Res Public Health. (2021) https:\/\/doi.org\/10.3390\/IJERPH18094796","DOI":"10.3390\/IJERPH18094796"},{"key":"1483_CR10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1086\/302858","volume":"66","author":"H El-Shanti","year":"2000","unstructured":"El-Shanti H, Lidral AC, Jarrah N, Druhan L, Ajlouni K. Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am J Hum Genet. 2000;66:1229\u201336.","journal-title":"Am J Hum Genet"},{"key":"1483_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/MOP.0b013e328354ccdf","volume":"24","author":"L Rigoli","year":"2012","unstructured":"Rigoli L, Di Bella C. Wolfram syndrome 1 and Wolfram syndrome 2. Curr Opin Pediatr. 2012;24:512\u20137.","journal-title":"Curr Opin Pediatr"},{"key":"1483_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1086\/520961","volume":"81","author":"S Amr","year":"2007","unstructured":"Amr S, Heisey C, Zhang M, Xia XJ, Shows KH, Ajlouni K, Pandya A, Satin LS, El-Shanti H, Shiang R. A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am J Hum Genet. 2007;81:673\u201383.","journal-title":"Am J Hum Genet"},{"key":"1483_CR13","doi-asserted-by":"publisher","unstructured":"Harding HP, Ron D Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes. (2002) https:\/\/doi.org\/10.2337\/DIABETES.51.2007.S455","DOI":"10.2337\/DIABETES.51.2007.S455"},{"key":"1483_CR14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1097-2765(01)00264-7","volume":"7","author":"HP Harding","year":"2001","unstructured":"Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, Ron D. Diabetes mellitus and exocrine pancreatic dysfunction in perk-\/- mice reveals a role for translational control in secretory cell survival. Mol Cell. 2001;7:1153\u201363.","journal-title":"Mol Cell"},{"key":"1483_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI39678","volume":"120","author":"SG Fonseca","year":"2010","unstructured":"Fonseca SG, Ishigaki S, Oslowski CM, et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest. 2010;120:744\u201355.","journal-title":"J Clin Invest"},{"key":"1483_CR16","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/hmg\/ddl081","volume":"15","author":"T Yamada","year":"2006","unstructured":"Yamada T, Ishihara H, Tamura A, et al. WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum Mol Genet. 2006;15:1600\u20139.","journal-title":"Hum Mol Genet"},{"key":"1483_CR17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1101\/gad.1779509","volume":"23","author":"YF Chen","year":"2009","unstructured":"Chen YF, Kao CH, Chen YT, et al. Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev. 2009;23:1183\u201394.","journal-title":"Genes Dev"},{"key":"1483_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.tips.2019.07.011","volume":"40","author":"D Abreu","year":"2019","unstructured":"\u2022\u2022 Abreu D, Urano F. Current landscape of treatments for Wolfram syndrome. Trends Pharmacol Sci. 2019;40:711\u20134. (This study emphasizes the treatment targeted at the endoplasmic reticulum stress pathogenesis of Wolfram syndrome.)","journal-title":"Trends Pharmacol Sci"},{"key":"1483_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s40618-013-0039-4","volume":"37","author":"F Lombardo","year":"2014","unstructured":"Lombardo F, Salzano G, Di Bella C, Aversa T, Pugliatti F, Cara S, Valenzise M, De Luca F, Rigoli L. Phenotypical and genotypical expression of Wolfram syndrome in 12 patients from a Sicilian district where this syndrome might not be so infrequent as generally expected. J Endocrinol Invest. 2014;37:195\u2013202.","journal-title":"J Endocrinol Invest"},{"key":"1483_CR20","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1210\/jc.2002-030015","volume":"89","author":"R Medlej","year":"2004","unstructured":"Medlej R, Wasson J, Baz P, Azar S, Salti I, Loiselet J, Permutt A, Halaby G. Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab. 2004;89:1656\u201361.","journal-title":"J Clin Endocrinol Metab"},{"key":"1483_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12967-019-1993-1","volume":"17","author":"MT Pallotta","year":"2019","unstructured":"Pallotta MT, Tascini G, Crispoldi R, Orabona C, Mondanelli G, Grohmann U, Esposito S. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med. 2019;17:238.","journal-title":"J Transl Med"},{"key":"1483_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1177\/112067210201200202","volume":"12","author":"M Al-Till","year":"2002","unstructured":"Al-Till M, Jarrah NS, Ajlouni KM. Ophthalmologic findings in fifteen patients with Wolfram syndrome. Eur J Ophthalmol. 2002;12:84\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"1483_CR23","doi-asserted-by":"publisher","first-page":"101452","DOI":"10.1016\/j.ajoc.2022.101452","volume":"26","author":"T Rotsos","year":"2022","unstructured":"Rotsos T, Papakonstantinou E, Symeonidis C, Krassas A, Kamakari S. Wolfram syndrome: a case report of two sisters Wolfram syndrome: case report of two sisters. Am J Ophthalmol case reports. 2022;26:101452.","journal-title":"Am J Ophthalmol case reports"},{"key":"1483_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000490535","volume":"241","author":"A Soares","year":"2019","unstructured":"Soares A, Mota \u00c1, Fonseca S, Faria O, Branda\u00f5 E, Falca\u00f5 Dos Reis F, Gentil R, Guimar\u00e3es S, Mendonca L. Ophthalmologic manifestations of Wolfram syndrome: report of 14 cases. Ophthalmologica. 2019;241:116\u20139.","journal-title":"Ophthalmologica"},{"key":"1483_CR25","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/S0140-6736(95)92473-6","volume":"346","author":"TG Barrett","year":"1995","unstructured":"Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet (London, England). 1995;346:1458\u201363.","journal-title":"Lancet (London, England)"},{"key":"1483_CR26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2337\/diacare.18.12.1566","volume":"18","author":"BT Kinsley","year":"1995","unstructured":"Kinsley BT, Swift M, Dumont RH, Swift RG. Morbidity and mortality in the Wolfram syndrome. Diabetes Care. 1995;18:1566\u201370.","journal-title":"Diabetes Care"},{"key":"1483_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/pr.2018.17","volume":"83","author":"L Rigoli","year":"2018","unstructured":"Rigoli L, Bramanti P, Di Bella C, De Luca F. Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. Pediatr Res. 2018;83:921\u20139.","journal-title":"Pediatr Res"},{"key":"1483_CR28","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00125-018-4679-y","volume":"61","author":"M Kondo","year":"2018","unstructured":"Kondo M, Tanabe K, Amo-Shiinoki K, Hatanaka M, Morii T, Takahashi H, Seino S, Yamada Y, Tanizawa Y. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia. 2018;61:2189\u2013201.","journal-title":"Diabetologia"},{"key":"1483_CR29","doi-asserted-by":"publisher","unstructured":"\u2022 Jagom\u00e4e T, Seppa K, Reimets R, et al \u00a0Early intervention and lifelong treatment with GLP1 receptor agonist liraglutide in a Wolfram syndrome rat model with an emphasis on visual neurodegeneration, sensorineural hearing loss and diabetic phenotype. Cells. (2021)\u00a0https:\/\/doi.org\/10.3390\/CELLS10113193An animal model study that shows promise to patients with Wolfram syndrome, in regard to the visual, hearing, and diabetes aspects of the disease.","DOI":"10.3390\/CELLS10113193"},{"key":"1483_CR30","doi-asserted-by":"publisher","unstructured":"Seppa K, Toots M, Reimets R, et al GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome. Sci Rep. (2019) https:\/\/doi.org\/10.1038\/S41598-019-52295-2","DOI":"10.1038\/S41598-019-52295-2"},{"key":"1483_CR31","doi-asserted-by":"publisher","unstructured":"Kakiuchi C, Ishigaki S, Oslowski CM, Fonseca SG, Kato T, Urano F Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. PLoS One. (2009) https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0004134","DOI":"10.1371\/JOURNAL.PONE.0004134"},{"key":"1483_CR32","first-page":"E5292","volume":"111","author":"S Lu","year":"2014","unstructured":"Lu S, Kanekura K, Hara T, et al. A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome. Proc Natl Acad Sci U S A. 2014;111:E5292\u2013301.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1483_CR33","doi-asserted-by":"publisher","first-page":"17389","DOI":"10.1073\/pnas.2007136117","volume":"117","author":"LD Nguyen","year":"2020","unstructured":"Nguyen LD, Fischer TT, Abreu D, Arroyo A, Urano F, Ehrlich BE. Calpain inhibitor and ibudilast rescue \u03b2 cell functions in a cellular model of Wolfram syndrome. Proc Natl Acad Sci U S A. 2020;117:17389\u201398.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1483_CR34","unstructured":"Washington University School of Medicine NI of H (NIH), (NIDDK) NI of D and D and KD A clinical trial of dantrolene sodium in pediatric and adult patients with Wolfram syndrome. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02829268."},{"key":"1483_CR35","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2337\/db13-0717","volume":"63","author":"L Shang","year":"2014","unstructured":"Shang L, Hua H, Foo K, et al. \u03b2-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes. 2014;63:923\u201333.","journal-title":"Diabetes"},{"key":"1483_CR36","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.3390\/ijerph19052755","volume":"19","author":"D Iafusco","year":"2022","unstructured":"Iafusco D, Zanfardino A, Piscopo A, et al. Metabolic treatment of Wolfram syndrome. Int J Environ Res Publ Health. 2022;19:2755.","journal-title":"Int J Environ Res Publ Health"},{"key":"1483_CR37","first-page":"325","volume":"7","author":"S Khambatta","year":"2014","unstructured":"Khambatta S, Nguyen DL, Beckman TJ, Wittich CM. Kearns-Sayre syndrome: a case series of 35 adults and children. Int J Gen Med. 2014;7:325\u201332.","journal-title":"Int J Gen Med"},{"key":"1483_CR38","doi-asserted-by":"crossref","unstructured":"Bj\u00f6rkman K, Vissing J, \u00d8stergaard E, et al Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study. J Med Genet jmedgenet-2021\u2013108006 (2021)","DOI":"10.1136\/jmedgenet-2021-108006"},{"key":"1483_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10545-014-9778-4","volume":"38","author":"A Broomfield","year":"2015","unstructured":"Broomfield A, Sweeney MG, Woodward CE, et al. Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. J Inherit Metab Dis. 2015;38:445\u201357.","journal-title":"J Inherit Metab Dis"},{"key":"1483_CR40","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Sequiera GL, Srivastava A, Alagarsamy KN, Rockman-Greenberg C, Dhingra S Generation and evaluation of isogenic iPSC as a source of cell replacement therapies in patients with Kearns Sayre syndrome. Cells (2021) 10:1\u201315 This important study demonstrated for the first time that peripheral blood mononuclear cell-induced pluripotent stem cells that represented an isogenic source of patient-specific personalized cell replacement therapies in Kearns\u2013Sayre syndrome.","DOI":"10.3390\/cells10030568"},{"key":"1483_CR41","doi-asserted-by":"publisher","unstructured":"Sabella-Jim\u00e9nez V, Otero-Herrera C, Silvera-Redondo C, Garavito-Galofre P Mitochondrial DNA deletion and duplication in Kearns-Sayre syndrome (KSS) with initial presentation as Pearson Marrow-Pancreas syndrome (PMPS): two case reports in Barranquilla, Colombia. Mol Genet genomic Med. (2020) https:\/\/doi.org\/10.1002\/MGG3.1509","DOI":"10.1002\/MGG3.1509"},{"key":"1483_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/0975-2870.126383","volume":"7","author":"K Bhatnagar","year":"2022","unstructured":"Bhatnagar K, Gupta D. Kearns Sayre syndrome. Med J Dr DY Patil Univ. 2022;7:252\u20135.","journal-title":"Med J Dr DY Patil Univ"},{"key":"1483_CR43","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s10038-008-0289-8","volume":"53","author":"S Yamashita","year":"2008","unstructured":"Yamashita S, Nishino I, Nonaka I, Goto YI. Genotype and phenotype analyses in 136 patients with single large-scale mitochondrial DNA deletions. J Hum Genet. 2008;53:598\u2013606.","journal-title":"J Hum Genet"},{"key":"1483_CR44","doi-asserted-by":"publisher","unstructured":"Epstein AE, Dimarco JP, Ellenbogen KA, et al ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. (2008) https:\/\/doi.org\/10.1161\/CIRCUALTIONAHA.108.189742","DOI":"10.1161\/CIRCUALTIONAHA.108.189742"},{"key":"1483_CR45","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1017\/S1047951118001609","volume":"28","author":"M Trivedi","year":"2018","unstructured":"Trivedi M, Goldstein A, Arora G. Prophylactic pacemaker placement at first signs of conduction disease in Kearns-Sayre syndrome. Cardiol Young. 2018;28:1487\u20138.","journal-title":"Cardiol Young"},{"key":"1483_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/S41536-021-00167-71093","author":"E Jacoby","year":"2021","unstructured":"\u2022\u2022 Jacoby E, Ben Yakir-Blumkin M, Blumenfeld-Kan S, et al. Mitochondrial augmentation of CD34 + cells from healthy donors and patients with mitochondrial DNA disorders confers functional benefit. NPJ Regen Med. 2021. https:\/\/doi.org\/10.1038\/S41536-021-00167-71093. (This revolutionary study supports mitochondria augmentation technology as a potential disease-modifying therapy for mtDNA disorders.)","journal-title":"NPJ Regen Med"},{"key":"1483_CR47","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Zhang S, Qiao Y, Wang Z, Zhuang J, Sun Y, Shang X, Li G\u00a0Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia. Clin Chim Acta (2021)\u00a0516:157\u2013168 This review summarizes the genotypes and phenotypes of most of the families described in the literature with thiamine-responsive megaloblastic anemia.","DOI":"10.1016\/j.cca.2021.01.025"},{"key":"1483_CR48","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/db17-0821","volume":"68","author":"P Jungtrakoon","year":"2019","unstructured":"\u2022 Jungtrakoon P, Shirakawa J, Buranasupkajorn P, et al. Loss-of-function mutation in thiamine transporter 1 in a family with autosomal dominant diabetes. Diabetes. 2019;68:1084\u201393. (A description of heterozygous carriers of the gene that causes thiamine-responsive megaloblastic anemia, which manifests as adult-onset diabetes.)","journal-title":"Diabetes"},{"key":"1483_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/jimd.12125","volume":"42","author":"A Marc\u00e9-Grau","year":"2019","unstructured":"Marc\u00e9-Grau A, Mart\u00ed-S\u00e1nchez L, Baide-Mairena H, Ortigoza-Escobar JD, P\u00e9rez-Due\u00f1as B. Genetic defects of thiamine transport and metabolism: a review of clinical phenotypes, genetics, and functional studies. J Inherit Metab Dis. 2019;42:581\u201397.","journal-title":"J Inherit Metab Dis"},{"key":"1483_CR50","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1086\/301642","volume":"61","author":"EJ Neufeld","year":"1997","unstructured":"Neufeld EJ, Mandel H, Raz T, Szargel R, Yandava CN, Stagg A, Faur\u00e9 S, Barrett T, Buist N, Cohen N. Localization of the gene for thiamine-responsive megaloblastic anemia syndrome, on the long arm of chromosome 1, by homozygosity mapping. Am J Hum Genet. 1997;61:1335\u201341.","journal-title":"Am J Hum Genet"},{"key":"1483_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jcjd.2020.11.006","volume":"45","author":"K Warncke","year":"2021","unstructured":"Warncke K, Prinz N, Iotova V, et al. Thiamine-responsive megaloblastic anemia-related diabetes: long-term clinical outcomes in 23 pediatric patients from the DPV and SWEET registries. Can J diabetes. 2021;45:539\u201345.","journal-title":"Can J diabetes"},{"key":"1483_CR52","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1399-5448.2012.00855.x","volume":"13","author":"C Shaw-Smith","year":"2012","unstructured":"Shaw-Smith C, Flanagan SE, Patch AM, et al. Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. Pediatr Diabetes. 2012;13:314\u201321.","journal-title":"Pediatr Diabetes"},{"key":"1483_CR53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/1753-0407.12556","volume":"10","author":"C Sun","year":"2018","unstructured":"Sun C, Pei Z, Zhang M, Sun B, Yang L, Zhao Z, Cheng R, Luo F. Recovered insulin production after thiamine administration in permanent neonatal diabetes mellitus with a novel solute carrier family 19 member 2 (SLC19A2) mutation. J Diabetes. 2018;10:50\u20138.","journal-title":"J Diabetes"},{"key":"1483_CR54","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/hmg\/11.23.2941","volume":"11","author":"R Di Giaimo","year":"2002","unstructured":"Di Giaimo R, Riccio M, Santi S, Galeotti C, Ambrosetti DC, Melli M. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum Mol Genet. 2002;11:2951\u201360.","journal-title":"Hum Mol Genet"},{"key":"1483_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2021.728043","author":"M Yang","year":"2021","unstructured":"\u2022 Yang M, Xu L, Xu C, Cui Y, Jiang S, Dong J, Liao L (2021) The mutations and clinical variability in maternally inherited diabetes and deafness: an analysis of 161 patients. Front Endocrinol (Lausanne). https:\/\/doi.org\/10.3389\/FENDO.2021.728043(This large summary of patients with maternally inherited diabetes and deafness emphasizes that young onset of diabetes with normal BMI, maternal inheritance, and impairments of multiple systems should prompt genetic testing)","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1483_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4158\/EP-2019-0270","volume":"26","author":"KN Robinson","year":"2020","unstructured":"Robinson KN, Terrazas S, Giordano-Mooga S, Xavier NA. The role of heteroplasmy in the diagnosis and management of maternally inherited diabetes and deafness. Endocr Pract. 2020;26:241\u20136.","journal-title":"Endocr Pract"},{"key":"1483_CR57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.endmts.2020.100074","volume":"2","author":"AS Ali","year":"2021","unstructured":"Ali AS, Ekinci EI, Pyrlis F. Maternally inherited diabetes and deafness (MIDD): an uncommon but important cause of diabetes. Endocr Metab Sci. 2021;2:5.","journal-title":"Endocr Metab Sci"},{"key":"1483_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1464-5491.2008.02359.x","volume":"25","author":"R Murphy","year":"2008","unstructured":"Murphy R, Turnbull DM, Walker M, Hattersley AT. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med. 2008;25:383\u201399.","journal-title":"Diabet Med"},{"key":"1483_CR59","doi-asserted-by":"publisher","unstructured":"Horikawa Y, Enya M Genetic dissection and clinical features of MODY6 (NEUROD1-MODY). Curr Diab Rep (2021) https:\/\/doi.org\/10.1007\/S11892-019-1130-9","DOI":"10.1007\/S11892-019-1130-9"},{"key":"1483_CR60","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1111\/cge.13749","volume":"97","author":"D Melis","year":"2020","unstructured":"Melis D, Carvalho D, Barbaro-Dieber T, et al. Primrose syndrome: characterization of the phenotype in 42 patients. Clin Genet. 2020;97:890\u2013901.","journal-title":"Clin Genet"},{"key":"1483_CR61","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2337\/db20-1174","volume":"70","author":"H Montaser","year":"2021","unstructured":"\u2022 Montaser H, Patel KA, Balboa D, et al. Loss of MANF causes childhood-onset syndromic diabetes due to increased endoplasmic reticulum stress. Diabetes. 2021;70:1006\u201318. (The first report of two patients with MANF disease. The first patient was reported earlier in 2015.)","journal-title":"Diabetes"},{"key":"1483_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaad.2013.09.019","volume":"70","author":"V Molho-Pessach","year":"2014","unstructured":"Molho-Pessach V, Ramot Y, Camille F, Doviner V, Babay S, Luis SJ, Broshtilova V, Zlotogorski A. H syndrome: the first 79 patients. J Am Acad Dermatol. 2014;70:80\u20138.","journal-title":"J Am Acad Dermatol"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-022-01483-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-022-01483-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-022-01483-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T09:17:19Z","timestamp":1659691039000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-022-01483-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1007\/s11892-022-01483-y","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"18 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}